Abstract
Photochemical internalization (PCI) is a novel technology for release of endocytosed macromolecules into the cytosol. The technology is based on the use of photosensitizers located in endocytic vesicles that upon activation by light induces a release of macromolecules from their compartmentalization in endocytic vesicles. PCI has been shown to enhance the biological activity of a large variety of macromolecules and other molecules that do not readily penetrate the plasma membrane, including type I ribosome-inactivating proteins (RIPs), gene-encoding plasmids, adenovirus, oligonucleotides, and the chemotherapeuticum bleomycin. PCI has also been shown to enhance the treatment effect of targeted therapeutic macromolecules. The results show that PCI can induce efficient light-directed delivery of macromolecules into the cytosol, indicating that PCI may have a variety of useful applications for site-specific drug delivery, e.g., in gene therapy, vaccination, and cancer treatment. Our studies also indicate that PCI of bleomycin is superior to PDT in targeting the tumor periphery and that this is partly the cause of the improved treatment effect of PCI as compared to PDT.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Varkouhi AK, Scholte M, Storm G, Haisma HJ (2011) Endosomal escape pathways for delivery of biologicals. J Control Release 151:220–228
Berg K, Selbo PK, Prasmickaite L, Tjelle TE, Kjølsrud S, Rodal GH, Anholt H, Sandvig K, Moan J, Gaudernack G, Fodstad Ø, Rodal SK, Høgset A (1999) Photochemical internalization. A novel technology for site-specific delivery of macromolecules into cytosol. Cancer Res 59:1180–1183
Selbo PK, Weyergang A, Høgset A, Norum OJ, Berstad MB, Vikdal M, Berg K (2010) Photochemical internalization provides time and space controlled endo-lysosomal escape of therapeutic molecules. J Control Release 148:2–12
Berg K, Dietze A, Kaalhus O, Høgset A (2005) Site-specific drug delivery by photochemical internalization enhances the antitumor effect of bleomycin. Clin Cancer Res 11:8476–8485
Høgset A, Prasmickaite L, Selbo PK, Hellum M, Engesæter BØ, Berg K (2004) Photochemical internalisation in drug and gene delivery. Adv Drug Deliv Res 56(1):95–115
Berg K, Nordstrand S, Selbo PK, Tran DTT, Angell-Petersen E, Høgset A (2011) Disulfonated tetraphenyl chlorin (TPCS2a), a novel photosensitizer developed for clinical utilization of photochemical internalization. Photochem Photobiol Sci 10:1637–1651
Pron G, Mahrour N, Orlowski S, Tounekti O, Poddevin B, Belehradek J Jr, Mir LM (1999) Internalisation of the bleomycin molecules responsible for bleomycin toxicity: a receptor—mediated endocytosis mechanism. Biochem Pharmacol 57:45–56
Poddevin B, Orlowski S, Belehradek Jr J, Mir LM (1991) Very high cytotoxicity of bleomycin introduced into the cytosol of cells in culture. Biochem Pharmacol 42:S67–67
Silve A, Leray I, Mir LM (2012) Demonstration of cell membrane permeabilization to medium-sized molecules caused by a single 10 ns electric pulse. Bioelectrochemistry 87:260–264
Selbo PK, Sivam G, Fodstad Ø, Sandvig K, Berg K (2001) In vivo documentation of photochemical internalization, a novel approach for site specific cancer therapy. Int J Cancer 92:761–766
Pastan I, Hassan R, Fitzgerald DJ, Kreitman RJ (2006) Immunotoxin therapy of cancer. Nat Rev Cancer 6:559–565
Selbo PK, Rosenblum MG, Cheung L, Zhang W, Berg K (2009) Multi-modality therapeutics with potent anti-tumor effects: photochemical internalization enhances delivery of the fusion toxin scFvMEL/rGel. PLoS ONE 4(8):e6691
Clarke M, Collins R, Darby S et al (2005) Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 366(9503):2087–2106
Norum O-J, Gaustad J-V, Angell-Petersen E, Rofstad1 EK, Peng Q, Giercksky KE, Berg K (2009) Photochemical internalization of bleomycin is superior to photodynamic therapy due to the therapeutic effect in the tumor periphery. Photochem Photobiol 85:740–49
Norum OJ, Giercksky KE, Berg K (2009) Photochemical internalization as an adjunct to marginal surgery in a human sarcoma model. Photochem Photobiol Sci 8:758–762
Mohamedali KA, Kedar D, Sweeney P, Kamat A, Davis DW, Eve BY, Huang S, Thorpe PE, Dinney CP, Rosenblum MG (2005) The vascular-targeting fusion toxin VEGF121/rGel inhibits the growth of orthotopic human bladder carcinoma tumors. Neoplasia 7:912–920
Abdel-Hady ES, Martin-Hirsch P, Duggan-Keen M, Stern PL, Moore JV, Corbitt G, Kitchener HC, Hampson IN (2001) Immunological and viral factors associated with the response of vulval intraepithelial neoplasia to photodynamic therapy. Cancer Res 61:192–196
Gollnick SO, Vaughan L, Henderson BW (2002) Generation of effective antitumor vaccines using photodynamic therapy. Cancer Res 62(6):1604–1608
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Berg, K., Weyergang, A., Vikdal, M., Norum, OJ., Selbo, P.K. (2014). Photochemical Internalization: A Novel Technology for Targeted Macromolecule Therapy. In: Abdel-Kader, M. (eds) Photodynamic Therapy. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-39629-8_6
Download citation
DOI: https://doi.org/10.1007/978-3-642-39629-8_6
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-39628-1
Online ISBN: 978-3-642-39629-8
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)